205 related articles for article (PubMed ID: 37347192)
1. Identification and Preliminary Characterization of Novel Type III Secreted Effector Proteins in Chlamydia trachomatis.
McCaslin PN; Andersen SE; Icardi CM; Faris R; Steiert B; Smith P; Haider J; Weber MM
Infect Immun; 2023 Jul; 91(7):e0049122. PubMed ID: 37347192
[TBL] [Abstract][Full Text] [Related]
2. Expression and targeting of secreted proteins from Chlamydia trachomatis.
Bauler LD; Hackstadt T
J Bacteriol; 2014 Apr; 196(7):1325-34. PubMed ID: 24443531
[TBL] [Abstract][Full Text] [Related]
3. Expression and localization of predicted inclusion membrane proteins in Chlamydia trachomatis.
Weber MM; Bauler LD; Lam J; Hackstadt T
Infect Immun; 2015 Dec; 83(12):4710-8. PubMed ID: 26416906
[TBL] [Abstract][Full Text] [Related]
4. Application of β-lactamase reporter fusions as an indicator of effector protein secretion during infections with the obligate intracellular pathogen Chlamydia trachomatis.
Mueller KE; Fields KA
PLoS One; 2015; 10(8):e0135295. PubMed ID: 26258949
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.
Fields KA; Hackstadt T
Mol Microbiol; 2000 Dec; 38(5):1048-60. PubMed ID: 11123678
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia trachomatis TmeA Directly Activates N-WASP To Promote Actin Polymerization and Functions Synergistically with TarP during Invasion.
Keb G; Ferrell J; Scanlon KR; Jewett TJ; Fields KA
mBio; 2021 Jan; 12(1):. PubMed ID: 33468693
[No Abstract] [Full Text] [Related]
7. The Loss of Expression of a Single Type 3 Effector (CT622) Strongly Reduces
Cossé MM; Barta ML; Fisher DJ; Oesterlin LK; Niragire B; Perrinet S; Millot GA; Hefty PS; Subtil A
Front Cell Infect Microbiol; 2018; 8():145. PubMed ID: 29868501
[TBL] [Abstract][Full Text] [Related]
8. Identification of type III secretion substrates of Chlamydia trachomatis using Yersinia enterocolitica as a heterologous system.
da Cunha M; Milho C; Almeida F; Pais SV; Borges V; Maurício R; Borrego MJ; Gomes JP; Mota LJ
BMC Microbiol; 2014 Feb; 14():40. PubMed ID: 24533538
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of affinity purification-mass spectrometry experimental systems used to identify eukaryotic and chlamydial proteins at the Chlamydia trachomatis inclusion membrane.
Olson MG; Ouellette SP; Rucks EA
J Proteomics; 2020 Feb; 212():103595. PubMed ID: 31760040
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel type III secretion chaperone-substrate complexes of Chlamydia trachomatis.
Pais SV; Milho C; Almeida F; Mota LJ
PLoS One; 2013; 8(2):e56292. PubMed ID: 23431368
[TBL] [Abstract][Full Text] [Related]
11. Context-Dependent Action of Scc4 Reinforces Control of the Type III Secretion System.
Gao L; Cong Y; Plano GV; Rao X; Gisclair LN; Schesser Bartra S; Macnaughtan MA; Shen L
J Bacteriol; 2020 Jul; 202(15):. PubMed ID: 32424009
[No Abstract] [Full Text] [Related]
12. Targeted Disruption of Chlamydia trachomatis Invasion by in Trans Expression of Dominant Negative Tarp Effectors.
Parrett CJ; Lenoci RV; Nguyen B; Russell L; Jewett TJ
Front Cell Infect Microbiol; 2016; 6():84. PubMed ID: 27602332
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARP.
Brinkworth AJ; Malcolm DS; Pedrosa AT; Roguska K; Shahbazian S; Graham JE; Hayward RD; Carabeo RA
Mol Microbiol; 2011 Oct; 82(1):131-44. PubMed ID: 21883523
[TBL] [Abstract][Full Text] [Related]
14. The Salmonella enterica serovar typhimurium-encoded type III secretion systems can translocate Chlamydia trachomatis proteins into the cytosol of host cells.
Ho TD; Starnbach MN
Infect Immun; 2005 Feb; 73(2):905-11. PubMed ID: 15664932
[TBL] [Abstract][Full Text] [Related]
15. Application of a
Yanatori I; Miura K; Chen YS; Valdivia RH; Kishi F
J Bacteriol; 2021 Jun; 203(11):. PubMed ID: 33685970
[No Abstract] [Full Text] [Related]
16. Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development.
Fields KA; Mead DJ; Dooley CA; Hackstadt T
Mol Microbiol; 2003 May; 48(3):671-83. PubMed ID: 12694613
[TBL] [Abstract][Full Text] [Related]
17. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development.
Hower S; Wolf K; Fields KA
Mol Microbiol; 2009 Jun; 72(6):1423-37. PubMed ID: 19460098
[TBL] [Abstract][Full Text] [Related]
18. The Chlamydia trachomatis type III secretion chaperone Slc1 engages multiple early effectors, including TepP, a tyrosine-phosphorylated protein required for the recruitment of CrkI-II to nascent inclusions and innate immune signaling.
Chen YS; Bastidas RJ; Saka HA; Carpenter VK; Richards KL; Plano GV; Valdivia RH
PLoS Pathog; 2014 Feb; 10(2):e1003954. PubMed ID: 24586162
[TBL] [Abstract][Full Text] [Related]
19. The Chlamydia trachomatis type III secretion substrates CT142, CT143, and CT144 are secreted into the lumen of the inclusion.
da Cunha M; Pais SV; Bugalhão JN; Mota LJ
PLoS One; 2017; 12(6):e0178856. PubMed ID: 28622339
[TBL] [Abstract][Full Text] [Related]
20. Conserved type III secretion system exerts important roles in Chlamydia trachomatis.
Dai W; Li Z
Int J Clin Exp Pathol; 2014; 7(9):5404-14. PubMed ID: 25337183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
